Indefinite Delivery Contract SPE2DR25D6046

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $9,999,999,999 and running through December 2036. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as a prime...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 2036. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The federal contract IDV award, valued at $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award indefinite delivery contract (IDC) spans from August 2025 through December 2036, providing worldwide pharmaceutical and medical supply support to various Department of Defense (DoD) customers, including the Defense Health Agency, US Coast...
The federal contract IDV award, valued at $9,999,999,999, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award Indefinite Delivery Contract (IDC) has an ultimate completion date of December 31, 2036 and serves as a vehicle for the DLA Troop Support Medical Supply Chain to obtain a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The federal contract IDV award is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs globally. It has a base period of 30 months and three 30-month option periods, for a total potential performance period through December 2036. The scope of the contract encompasses a wide range...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, which runs through December 2036, is intended to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contract encompasses a broad range of pharmaceutical and...
The federal contract IDV award, valued at $9,999,999,999, was granted to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award Indefinite Delivery Contract (IDC) has an ultimate completion date of December 31, 2036 and covers the procurement of a comprehensive range of pharmaceutical and medical products to support various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval...
The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Pharmaceutical Prime Vendor Global Program Generation V contract. The $999,999,999 Indefinite Delivery Contract (IDC) has a 30-month base period and three 30-month option periods, running through December 2036. The contract is intended to provide worldwide pharmaceutical support, including brand-name, generic,...
The federal contract IDV award, valued at $9,999,999,999, was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2036, is an Indefinite Delivery Contract (IDC) that enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes...

The federal contract IDV award is a $999,999,999 Indefinite Delivery Contract (IDC) from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The IDC serves as a prime vehicle for the DLA to procure essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC, along with a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, enables efficient government procurement of critical pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The original solicitation indicates this is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation approach, with the intent to make multiple regional awards to ensure pharmaceutical supply chain resiliency.

Generated 6/6/25, 9:55 AM